What is Methamphetamine?
Methamphetamine is a synthetic stimulant drug belonging to the amphetamine class. It is chemically similar to amphetamine but has greater potency and longer duration of action. Methamphetamine activates the sympathetic nervous system and produces intense euphoria, increased energy, and heightened alertness.
Very Limited Medical Use (Desoxyn):
Methamphetamine has one FDA-approved medical use:
-
Desoxyn (methamphetamine hydrochloride tablets): Rarely prescribed for severe ADHD (Attention Deficit Hyperactivity Disorder) when other treatments have failed
IMPORTANT: Desoxyn is rarely prescribed (less than 0.01% of ADHD prescriptions). The vast majority of methamphetamine use is illicit. Medical methamphetamine is never available in retail pharmacy settings for outpatient dispensing without strict DEA controls.
Street Names:
-
Meth
-
Crystal
-
Crystal meth
-
Ice
-
Tina
-
Speed (ambiguous, also used for amphetamine)
-
Crank
-
Glass
-
Shards
-
Chalk
-
Tweak
Common Forms and Appearance:
| Form | Appearance | Typical Use |
|---|---|---|
| Powder | White or off-white fine powder | Snorted, swallowed, dissolved for injection |
| Crystal (“Crystal meth”) | Clear to bluish-white crystalline shards | Smoked, crushed and snorted/injected |
| Pill (illicit) | Various colors, often imprinted | Swallowed, crushed |
| Liquid | Dissolved in water/alcohol | Injected |
Routes of Administration and Onset:
| Route | Onset | Duration of High | Additional Risks |
|---|---|---|---|
| Smoked | Seconds (most rapid) | 4-8 hours | Lung damage, rapid addiction |
| Injected (IV) | Seconds | 4-8 hours | Needle sharing (HIV, Hepatitis), infections |
| Snorted | 3-5 minutes | 6-12 hours | Nasal damage, septum perforation |
| Swallowed | 15-30 minutes | 8-12+ hours | Slower onset, longer duration |
How Methamphetamine Works (Mechanism of Action):
Methamphetamine is a powerful monoamine releaser that floods the brain with three key neurotransmitters:
| Neurotransmitter | Effect of Increased Levels |
|---|---|
| Dopamine | Intense euphoria, reward, motivation, addiction |
| Norepinephrine | Increased energy, alertness, heart rate, blood pressure |
| Serotonin | Mood elevation, appetite suppression |
Unlike cocaine (which blocks reuptake), methamphetamine causes neurons to release large amounts of these neurotransmitters AND blocks their reuptake — resulting in a more prolonged and intense effect.
Immediate Physical Effects:
-
Extreme increase in heart rate and blood pressure
-
Rapid breathing
-
Dilated pupils
-
Decreased appetite
-
Increased body temperature (hyperthermia)
-
Sweating and dry mouth
-
Tremors and muscle twitching
-
Teeth grinding (bruxism)
-
Reduced need for sleep
Immediate Psychological Effects:
-
Intense euphoria (“rush”)
-
Increased energy and activity
-
Heightened alertness and focus
-
Grandiosity and overconfidence
-
Increased libido
-
Anxiety and irritability
-
Paranoia
-
Aggressive or violent behavior
-
Psychosis (at high doses)
Short-Term Health Risks:
| Risk | Description |
|---|---|
| Hyperthermia | Dangerously high body temperature leading to organ damage |
| Seizures | Neurological complication, especially at high doses |
| Cardiac events | Heart attack, arrhythmia, sudden cardiac death |
| Stroke | Due to extreme vasoconstriction and high blood pressure |
| Rhabdomyolysis | Breakdown of muscle tissue, kidney failure |
| Dehydration | From sweating, reduced thirst perception |
| Hyponatremia | Low sodium from excessive water intake (less common) |
Long-Term Health Consequences:
| Consequence | Description |
|---|---|
| Meth mouth | Severe tooth decay, gum disease, tooth loss from dry mouth, teeth grinding, poor hygiene |
| Skin sores | Formication (sensation of insects crawling on skin) leading to compulsive picking |
| Weight loss | Severe malnutrition, wasting syndrome |
| Cardiomyopathy | Permanent heart muscle damage |
| Brain damage | Damage to dopamine and serotonin neurons, cognitive impairment |
| Memory loss | Impaired verbal learning and memory |
| Psychosis | Paranoia, hallucinations (tactile, auditory, visual), delusions |
| Parkinsonism | Movement disorders similar to Parkinson’s disease |
| Infectious diseases | HIV, Hepatitis B and C from needle sharing |
| Abscesses and infections | From injection use |
Methamphetamine-Induced Psychosis:
Chronic use can cause psychotic symptoms that may persist for months or years after stopping use:
| Symptom | Description |
|---|---|
| Paranoia | Intense, irrational suspicion (e.g., being followed, poisoned) |
| Hallucinations | Formication (“crank bugs” — feeling insects crawling under skin) |
| Delusions | False beliefs (e.g., being surveilled, having special powers) |
| Aggression | Violent outbursts, hostility |
| Thought disorder | Disorganized thinking, speech |
Overdose Signs:
| Sign | Description |
|---|---|
| Extreme agitation | Severe restlessness, pacing, violence |
| Seizures | Convulsions |
| Hyperthermia | Body temperature >104°F (40°C) |
| Severe hypertension | Dangerously high blood pressure |
| Chest pain | Possible heart attack |
| Difficulty breathing | Respiratory distress |
| Loss of consciousness | Coma |
| Stroke symptoms | Facial droop, arm weakness, speech difficulty |
Overdose Response:
-
Call 911 or local emergency services immediately
-
Try to keep the person calm and cool (apply cool compresses, remove excess clothing)
-
Do not restrain forcefully unless danger to self/others
-
Do not give anything by mouth if unconscious or seizing
-
If unknown substance (possible opioid/fentanyl), administer naloxone — it won’t reverse meth but may reverse opioids
-
Provide emergency responders with information about what was taken (if known)
Tolerance, Dependence, and Withdrawal:
| Property | Assessment |
|---|---|
| Tolerance | Develops rapidly; users need higher doses to achieve same effect |
| Physical dependence | Moderate to high |
| Psychological dependence | Very high (strong cravings) |
| Addiction potential | Extremely high (one of the most addictive substances) |
Withdrawal Symptoms (Crash):
Withdrawal begins within 24 hours of last use and can last 1-3 weeks or longer:
| Phase | Timeframe | Symptoms |
|---|---|---|
| Crash | Days 1-3 | Extreme fatigue, excessive sleep (12-24+ hours), depression, anxiety, increased appetite |
| Withdrawal | Days 4-14 | Intense cravings, depression, irritability, agitation, vivid nightmares, difficulty concentrating |
| Protracted | Weeks to months | Anhedonia (inability to feel pleasure), memory problems, mood swings, drug cravings |
Pregnancy and Breastfeeding:
| Stage | Risk |
|---|---|
| Pregnancy | Premature birth, low birth weight, placental abruption, neonatal withdrawal (irritability, feeding difficulties), developmental problems |
| Breastfeeding | Methamphetamine passes into breast milk, causing irritability, poor feeding, insomnia in infants. Not recommended. |
Drug Interactions (Major):
| Drug Class | Interaction | Risk |
|---|---|---|
| MAO inhibitors (antidepressants) | Hypertensive crisis, hyperthermia, seizures | Life-threatening |
| Other stimulants (cocaine, MDMA) | Excessive CNS stimulation | Heart attack, seizure |
| Alcohol | Masks intoxication, increased heart strain, severe dehydration | Overdose, alcohol poisoning |
| Antidepressants (SSRIs) | Serotonin syndrome | Agitation, hyperthermia |
| Opioids | Respiratory depression risk (opposite effects on heart) | Death |
Legal Status (By Jurisdiction):
| Country/Region | Classification | Penalty for Possession |
|---|---|---|
| United States (federal) | Schedule II | Up to 1-5 years imprisonment + fines (depends on quantity) |
| United Kingdom | Class A | Up to 7 years imprisonment + unlimited fine |
| Canada | Schedule I | Up to 7-10 years imprisonment |
| Australia | Schedule 8 | Up to 2 years (small quantity) to life (commercial quantity) |
| Japan | Stimulants Control Law | Up to 10-20 years imprisonment |
| New Zealand | Class A | Up to 6 months imprisonment (possession) |
Demographics and Public Health Impact (US Data – Educational):
| Statistic | Data (approximate) |
|---|---|
| Past-year methamphetamine users (US) | ~2.5 million |
| Methamphetamine use disorder cases (US) | ~1.5 million |
| Overdose deaths involving meth (2021, US) | ~32,000 |
| Increase in meth deaths (2015-2021) | >500% |
| Methamphetamine co-involved with fentanyl | ~50% of meth overdose deaths |
Harm Reduction Information (Educational Only):
For individuals who choose to use despite legal and health risks:
| Recommendation | Rationale |
|---|---|
| Do not use alone | Someone can call for help if overdose occurs |
| Use lower doses | Risk of overdose increases with dose and purity |
| Avoid injection | Reduces HIV/Hepatitis risk, vein damage, overdose risk |
| Use clean equipment | Never share needles, pipes, straws |
| Avoid mixing with opioids or alcohol | Significantly increases overdose risk |
| Stay hydrated | Meth causes dehydration, but avoid overhydration |
| Cool down if overheating | Hyperthermia is a leading cause of meth death |
| Seek help for psychosis | If paranoid or hallucinating, get medical evaluation |
| Carry naloxone | Meth is often contaminated with fentanyl |
Where to Get Help for Substance Use:
| Resource | Contact | Purpose |
|---|---|---|
| SAMHSA Helpline (US) | 1-800-662-4357 | Substance use support, confidential, 24/7 |
| 911 / Emergency | 911 | Life-threatening emergency (overdose, seizure, psychosis) |
| Poison Control (US) | 1-800-222-1222 | Overdose guidance |
| Never Use Alone | 1-877-696-1996 | Overdose hotline for those using alone |
| National Suicide Prevention Lifeline | 988 (US) | Crisis support |
| Local addiction treatment providers | Search “substance use treatment near me” | Long-term recovery |
Key Educational Message:
Methamphetamine is one of the most dangerous and addictive illicit substances. Chronic use leads to severe physical deterioration (meth mouth, skin sores, weight loss), permanent brain damage, psychosis, and death. There is no safe dose of illicit methamphetamine. Fentanyl contamination is increasingly common. If you or someone you know is using methamphetamine, seek professional help. Recovery is possible with evidence-based treatment including cognitive-behavioral therapy and contingency management. There are no FDA-approved medications for methamphetamine use disorder at this time.




